Richard E. Chipkin Ph.D.
Chief Executive Officer and Director,Psychiatric Genomics, Inc.
|Age||Total Calculated Compensation||This person is connected to 17 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Dr. Richard E. Chipkin, Ph.D., serves as the Chief Executive Officer and President of Psyadon Pharmaceuticals, Inc. Most recently, Dr. Chipkin served as Chief Executive Officer of Psychiatric Genomics, Inc. since August 2001 and also served as its President. Previously, Dr. Chipkin was in the global business development group at Schering-Plough. Dr. Chipkin has more than 20 years experience at both biotech and big pharmaceutical companies. Prior to that, he worked at ...
1211 Parklawn DrivePhone: --
Rockville, Maryland 20852
Board Members Memberships*
Chief Executive Officer and Director
State University of New York
Virginia Commonwealth University's School of Medicine
University of Colorado Denver
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.